What is Percorso Life Sciences?
Percorso Life Sciences operates as a specialized logistics and business process outsourcing provider, uniquely tailored to the needs of the life sciences sector. With over 15 years of operational expertise, the firm facilitates the seamless entry of European manufacturers into the US market by managing complex supply chain, diagnostic, and commercial support functions. Their white-label service model allows clients to maintain full control over brand identity, pricing, and customer relationships, effectively mitigating the logistical friction typically associated with cross-border expansion. By addressing the challenges of time zones and geographic distance, Percorso serves as a critical operational partner for academic, pharmaceutical, and diagnostic organizations aiming to scale their commercial footprint in North America.
How much funding has Percorso Life Sciences raised?
Percorso Life Sciences has raised a total of $65K across 1 funding round:
Debt
$65K
Debt (2021): $65K with participation from PPP
Key Investors in Percorso Life Sciences
PPP
Public-Private Partnership
What's next for Percorso Life Sciences?
With the infusion of this recent capital, Percorso Life Sciences is poised to accelerate its strategic growth initiatives. The company is expected to focus on scaling its rapid delivery solutions and deepening its penetration within the US biotech and pharmaceutical sectors. As the demand for localized, high-touch commercial support continues to rise, Percorso will likely invest in enhancing its technological infrastructure to further streamline the integration of international manufacturers into the US ecosystem. This phase of development is critical for the firm as it seeks to solidify its market position as the premier partner for non-US life science companies navigating the complexities of the American regulatory and commercial landscape.
See full Percorso Life Sciences company page
